Endocrinological assessment of secondary amenorrhoea and oligomenorrhea with particular focus on the polycystic ovary syndrome (PCOS);Endokrinologische diagnostik der sekundaren amenorrho und oligomenorrho unter besonderer berucksichtigung des polyzystischen ovar-syndroms

Geburtshilfe und Frauenheilkunde

Volumn 58, Issue 3, 1998, Pages 139-151

  Luppa, P ^a   Seifert Klauss, V ^b   Hoß C ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; THYROTROPIN;

ALGORITHM; DISEASE CLASSIFICATION; HORMONE DETERMINATION; HUMAN; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PATHOLOGICAL ANATOMY; REVIEW; SECONDARY AMENORRHEA;

EID: 0031918151     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1022137     Document Type: Review

References (129)

1. Adams, J., D. W. Poison, S. Franks: Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J. 293 (1986) 355-359.
2. Albarracin, C. T., G. Gibori: Prolactin action on luteal protein expression in the corpus luteum. Endocrinology 129 (1991) 1821-1830.
3. Anonymous: Hyperprolactinaemia: when is a prolactinoma not a prolactinoma? Lancet II (1987) 1002-1004.
4. Anonymous: ACOG technical bulletin. Hyperandrogenic chronic anovulation. Int. J. Gynecol. Obstet. 49 (1995) 201-208.
5. Asherman, J. G.: Amenorrhoea traumatica. J. Obstet. Gynaecol. Br. Emp. 55 (1948) 23-30.
6. Azziz, R., D. Dewailly, D. Owerbach: Clinical review 56. Nonclassic adrenal hyperplasia: current concepts. J. Clin. Endocrinol. Metab. 78 (1994) 810-815.
7. Azziz, R.: 21-Hydroxylase-deficient nonclassic adrenal hyperplasia. The Endocrinologist 5 (1995) 297-303.
8. Baird, D. T.: Amenorrhoea. Lancet 350 (1997) 275-279.
9. Balen, A. H., G. S. Conway, G. Kaltsas, K. Techatrasak, P. J. Manning, C. West, H. S. Jacobs: Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum. Reprod. 10 (1995) 2107-2111.
10. Barnes, R. B., R. L. Rosenfield, S. Burstein, D. A. Ehrmann: Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N. Engl. J. Med. 320 (1989) 559-565.
11. Bevan, J. S., C. W. Burke: Interpreting prolactin levels. Lancet II (1987) 1457.
12. Breckwoldt, M., J. W. Siebers, U. Müller: Die primäre Ovarialinsuffizienz. Gynäkologe 14 (1981) 131-144.
13. Breckwoldt, M., H. P. Zahradnik, P. Wieacker: Hirsutism, its pathogenesis. Human Reproduction 4 (1989) 601-604.
14. Breckwoldt, M., B. Runnebaum, O. A. Müller: Weibliche Gonaden. In: Rationelle Diagnostik in der Endokrinologie, Hrsg.: Deutsche Gesellschaft für Endokrinologie. Georg Thieme Verlag Stuttgart (1993) 213-221.
15. Bulusu, S.: Secondary amenorrhoea. J. Roy. Soc. Med. 89 (1996) 220-221.
16. Burghen, G. A., J. R. Givens, A. E. Kitabchi: Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J. Clin. Endocrinol. Metab. 50 (1980) 11311-11318.
17. Carlström, K., S. Gershagen, G. Rannevik: Free testosterone and testosterone/SHBG index in hirsute women: a comparison of diagnostic accuracy. Gynecol. Obstet. Invest. 24 (1987) 256-261.
18. Cavaliere, H., G. A. Medeiros-Neto, W. Rosner, I. A. Kourides: Persistent pituitary resistance to thyroid hormone in congenital versus later-onset hypothyroidism. J. Endocrinol. Invest. 8 (1985) 527-532.
19. Cavaliere, H., N. Abelin, G. Medeiros-Neto: Serum levels of total testosterone and sex hormone binding globulin in hypothyroid patients and normal subjects treated with incremental doses of L-T4 or L-T3.J. Androl. 9 (1988) 215-219.
20. Chatterjee, R., M. Katz, T. F. Cox, J. B. Porter: Prospective study of the hypothalamic-pituitary axis in thalassaemic patients who developed secondary amenorrhoea. Clin. Endocrinol. Oxf. 39 (1993) 287-296.
21. Considine, R. V., M. K. Sinha, M. L. Heiman, A. Kriauciunas, T. W. Stephens, M. R. Nyce, J. P. Ohannesian, C. C. Marco, L. J. McKee, T. L. Bauer, J. F. Caro: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334 (1996) 292-295.
22. Cheung, A. P., R. J. Chang: Polycystic Ovary Syndrome. Clin. Obstet. Gynecol. 33 (1990) 655-667.
23. Clayton, R. N., V. Ogden, J. Hodgkinson, L. Worswick, D. A. Rodin, S. Dyer, T. W. Meade: How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin. Endocrinol. 37 (1992) 127-134.
24. Conway, G. S., G. Kaltsas, A. Patel, M. C. Davies, H. S. Jacobs: Characterization of idiopathic premature ovarian failure. Fertil. Steril. 65 (1996) 337-341.
25. Crosignani, P. G., W. Vegetti: A practical guide to the diagnosis and management of amenorrhea. Drugs 52 (1996) 671-681.
26. Davies, J. S., N. P. Hinds, M. F. Scanlon: Growth hormone deficiency and hypogonadism in a patient with multiple sclerosis. Clin. Endocrinol. Oxf. 44 (1996) 117-119.
27. Dunaif, A., M. Graf, J. Mandeli, V. Laumas, A. Dobrjansky: Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J. Clin. Endocrinol. Metab. 65 (1987) 499-507.
28. Dunaif, A., K. R. Segal, W. Futterweit, A. Dobrjansky: Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38 (1989) 1165-1174.
29. Dunaif, A., D. Scott, B. Finegood, B. Quintana, R. Whitcomb: The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 81 (1996) 3299-3306.
30. Dusza, I.: Effect of prolactin on ovarian steroidogenesis. Acta Physiol. Pol. 40 (1989) 74-84.
31. Egger, H. J.: Untersuchungen des Steroidstoffwechsels bei endokrinen Störungen mit der Kombination Glaskapillargaschromatographie-Massenspektrometrie. Dissertation an der Mathematisch-Naturwissenschaftlichen Fakultät der Georg-August-Universitat zu Göttingen (1977).
32. Ehrmann, D. A., D. J. Schneider, B. E. Sobel, M. K. Cavaghan, J. Imperial, R. L. Rosenfield, K. S. Polonsky: Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 82 (1997) 2108-2116.
33. Emmanouel, D. S., M. D. Lindheimer, A. I. Katz: Pathogenesis of endocrine abnormalities in uremia. Endocrine Rev. 1 (1980) 28-44.
34. Erikson, G. F., D. A. Magoffin, C. A. Dyer, C. Hofeditz: The ovarian androgen producing cells: a review of structure/function relationship. Endocrine Rev. 6 (1985) 371-399.
35. Farina, G., C. Pedrotti, P. Cerani, A. Rovati, E. Strada, G. Bergamaschi, L. Montanari: Successful pregnancy following gonadotropin therapy in a young female with juvenile idiophatic hemochromatosis and secondary hypogonadotropic hypogonadism. Haematologica 80 (1995) 335-337.
36. Ferin, M., R. Jewelewicz, M. P. Warren: The menstrual cycle. Oxford University Press, New York (1993).
37. Fox, R., E. Corrigan, P. G. Thomas, M. G. R. Hull: Oestrogen and androgen states in oligo-amenorrhoeic women with polycystic ovaries, Br. J. Obstet, Gynaecol. 98 (1991) 294-299.
38. Franks, S.: Primary and secondary amenorrhoea. Br. Med. J. 294 (1987) 815-819.
39. Franks, S.: Polycystic ovary syndrome: a changing perspective. Clin. Endocrinol. 31 (1989) 87-120.
40. Franks, S.: Polycystic ovary syndrome. N. Engl. J. Med. 333 (1995) 853-861.
41. Geisthovel, F.: Zyklusstörungen, Amenorrhö. In: Praktische Endokrinologie., Hrsg.: Allolio, B., H. M. Schulte. Urban & Schwarzenberg, München (1996) 438-446.
42. Geisthövel, F., B. Frorath, C. Brabant: Acarbose reduces elevated testosterone serum concentrations in hyperinsulinaemic premenopausal women: a pilot study. Hum. Reprod. 11 (1996) 2377-2381.
43. Genazzani, A. D., F. Petraglia, G. Fabbri, A. Monzani, V. Montanini, A. R. Genazzani: Evidence of luteinizing hormone secretion in hypothalamic amenorrhea associated with weight loss. Fertil. Steril. 54 (1990) 222-226.
44. Graf, M., C. Weiers, C. Graf, A. Umlauf, W. Distler: Dexamethason normalisiert nicht die gestörte LH-Pulsatilität bei der hyperandrogenämischen Ovarialinsuffizienz. Geburtsh. u. Frauenheilk. 52 (1992) 35-41.
45. Hanker, J. P.: Schilddrüse und Fertilität der Frau. Med. Welt 42 (1991) 12-14.
46. Hardt, W. O., V. Borgmann, J. Sandow: Gonadotropin-Releasing-Hormon: LH-RH-Physiologie und Substitutionstherapie. Dt. Ärztebl. 84 (1987) B 1873-1876.
47. Hens, L. P. Devroey, L. Van-Waesberghe, M. Bonduelle, A. C. Van-Steirteghem, I. Liebaers: Chromosome studies and fertility treatment in women with ovarian failure. Clin. Genet. 36 (1989) 81-91.
48. Hörl, W. H., W. Riegel, C. Wanner, M. Haag-Weber, P. Schollmeyer, H. Wieland, H. Wilms: Endocrine and metabolic abnormalities following kidney-transplantation. Klin. Wochenschr. 67 (1989) 907-918.
49. Hoffman, D. I., K. Klove, R. A, Lobo: The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women. Fertil. Steril. 42 (1984) 76-81.
50. Homburg, R.: Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy. Hum. Reprod. 11 (1996) 29-39.
51. Jalal, S. M., R. Dahl, L. Erickson, D. Zimmerman, N. Lindor: Cytogenetic and clinical characteristics of a case involving complete duplication of Xpter → Xq 13.J. Med. Genet. 33 (1996) 237-239.
52. Jacobs, H. S., U. A. Knuth, M. G. R. Hull, S. Franks: Post-"pill" amenorrhoea - cause or coincidence? Br. Med. J. 2 (6092) (1977) 940-942.
53. Jarret, J. C., C. Ballejo, J. C. M. Tsibris, W. N. Spellacy: Insulin binding to human ovaries. J. Clin. Endocrinol. Metab. 60 (1985) 460-463.
54. Kallenberg, G. A., C. M. Pesce, B. Norman, R. E. Ratner, S. G. Silbergerg: Ectopic hyperprolactinemia resulting from an ovarian teratoma. JAMA 263 (1990) 2472-2474.
55. Kawagoe, S., M. Hiroi: Involvement of prolactin in the control of follicular maturation. Gynecol. Obstet. Invest. 29 (1990) 51-55.
56. Kjaer, K., C. Hagen, S. H. Sando, O. Eshoj: Epidemiology of menarche and menstrual disturbances in an unselected group of women with insulin-dependent diabetes mellitus compared to controls. J. Clin. Endocrinol. Metab. 75 (1992) 524-529.
57. Krolikowski, A., K. Janowski, J. V. Larsen: Asherman syndrome caused by schistosomiasis. Obstet. Gynecol. 85 (1995) 898-899.
58. KUSS, E.: Hormonbestimmungen. In: Gynäkologie und Geburtshilfe, Band 1/1 Sexuelle Differenzierung, Genetik, Fortpflanzung, Kindheit und Pubertät. Hrsg.: J. Zander, G. Thieme Verlag, Stuttgart (1987) 4.168-4.221.
59. Lalich, R. A., J. Aiman: Pituitary sarcoidosis causing secondary amenorrhea. A case report. J. Reprod. Med. 35 (1990) 737-740.
60. Laughlin, G. A., A. J. Morales, S. S. C. Yen: Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia. J. Clin. Endocrinol. Metab. 82 (1997) 1692-1696.
61. Lobo, R. A., L. Granger, U. Goebelsmann, D. R. Mishell: Elevations in unbound serum E2 as a possible mechanism for inappropriate gonadotropin secretion in women with PCO. J. Clin. Endocrinol. Metab. 52 (1981) 156-158.
62. Lobo, R. A.: The role of the adrenal in the polycystic ovary syndrome. Semin. Reprod. Endocrinol. 2 (1984) 251-257.
63. Luppa, P., B. Müller, K. Jacob, R. Kimmig, T. Strowitzki, C. Höß, M. M. Weber, D. Engelhardt, R. A. Lobo: Variations of steroid hormone metabolites in serum and urine in polycystic ovary syndrome after nafarelin stimulation: evidence for an altered corticoid excretion J. Clin. Endocrinol. Metab. 80 (1995) 280-288.
64. Luppa, P., D. Neumeier, R. Kimmig: Rationelle Labordiagnostik des Hyperandrogenismus der Frau. Ärztl. Lab. 10 (1989) 247-252.
65. Maroulis, G. B.: Evaluation of hirsutism and hyperandrogenemia. Fertil. Steril. 36 (1981) 273-305.
66. McArthur, J. W., F. M. Ingersoll, J. Worcester: The urinary excretion of interstitial cell and follicle-stimulating hormone activity by women with disease of the reproductive system. J. Clin. Endocrinol. 18 (1958) 1202-1210.
67. McClure, N., O. Henry, J. M. Harley: Pure XY gonadal dysgenesis presenting as secondary amenorrhoea. A case report. J. Reprod. Med. 37 (1992) 291-292.
68. McKenna, T. J.: Pathogenesis and treatment of polycystic ovary syndrome, N. Engl. J. Med. 318 (1988) 558-562.
69. Mehta, A., I. Matwijw, P. J. Taylor, E. A. Salamon, J. V. Kredentser, C. Faiman: Should androgen levels be measured in hirsute women with normal menstrual cycles? Int. J. Fertil. 37 (1992) 354-357.
70. Midro, A. T., B. Panasiuk, J. Radwan, I. Sipowicz, B. Jaworowska, E. Korsak: Les aberrations des chromosomes sexuels chez les patients presentant des troubles de la menstruation. J. Gynecol. Obstet. Biol. Reprod. Paris 19 (1990) 811-816.
71. Miller, W. L.: Pathophysiology, genetics and treatment of hyperandrogenism. Pediatr. Clin. N. Amer. 44 (1997) 375-395.
72. Moll, G. W., R. L. Rosenfield: Plasma free testosterone in the diagnosis of adolescent polycystic ovary syndrome. J. Pediatr. 102 (1983) 461-464.
73. Moltz, L., M. Trapp, G. Bispink, F. Leidenberger: Rationelle hormonale Diagnostik der sekundären Amenorrhö. Geburtsh. u. Frauenheilk. 47 (1987) 228-239.
74. Moltz, L., F. Leidenberger: Rationelle Endokrinologische Diagnostik in der Gynäkologie und Geburtshilfe einschließlich der Reproduktionsmedizin. HUF-Verlag, Mülheim an der Ruhr (1994).
75. Moltz, L. F. Leidenberger, C. Weise: Rationelle hormonale Diagnostik der normozyklischen funktionellen Sterilität. Geburtsh. u. Frauenheilk. 51 (1991) 756-768.
76. Müller, B.: Evaluierung der diagnostischen Bedeutung des Nafarelin-Tests bei Patientinnen mit Polyzystischem Ovar-Syndrom. Dissertation an der Medizinischen Fakultät der Technischen Universität München (1996).
77. Münster, K., P. Helm, L. Schmidt: Secondary amenorrhea: Prevalence and medical contact - a cross-sectional study from a Danish county. Br. J. Obstet. Gynaecol. 99 (1992) 430-433.
78. Nestler, J. E., L. P. Powers, D. W. Matt, K. A. Steingold, S. R. Plymate, R. S. Rittmaster, J. N. Clore, W. O. Blackard: A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 72 (1991) 83-89.
79. Nestler, J. E., D. J. Jakubowicz: Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N. Engl. J. Med. 335 (1996) 617-623.
80. Nobels, F., D. Dewailly: Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis. Fertil. Steril. 58 (1992) 655-666.
81. Pettersson, F., H. Fries, S. J. Nillius: Epidemiology of secondary Hamenorrhea. I. Incidence and prevalence rates. Am. J. Obstet. Gynecol. 117 (1973) 80-86.
82. Pettigrew, R., D. Hamilton-Fairley: Obesity and female reproductive function, Br. Med. Bull. 53 (1997) 341-358.
83. Plymate, S. R., L. A. Matej, R. E. Jones, K. E. Friedl: Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J. Clin. Endocrinol. Metab. 67 (1988) 460-464.
84. Polson, D. W., J. Adams, J. Wadsworth, S. Franks: Polycystic ovaries - a common finding in normal women. Lancet I (1988) 870-872.
85. Rebar, R., H. L. Judd, S. S. C. Yen, J. Rakoff, G. Vandenberg, F. Naftolin: Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J. Clin. Invest. 57 (1976) 1320-1329.
86. Raimondi, E., R. Vagnarelli, M. Bensi, L. De-Carli: Characterization of an X;X translocation by cytological analysis and in situ hybridization. Cytogenet. Cell. Genet. 50 (1989) 123-124.
87. Reindollar, R. H., M. Novak, S. P. T. Tho, P. G. McDonough: Adultonset amenorrhea: a study of 262 patients. Am. J. Obstet. Gynecol. 155 (1986) 531-543.
88. Rittmaster, R. S., D. L. Loriaux: Hirsutism. Ann. Intern. Med. 106 (1987) 95-107.
89. Rodin, A., H. Thakkar, N. Taylor, R. Clayton: Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11β-hydroxysteroid dehydrogenase. N. Engl. J. Med. 330 (1994) 460-465.
90. Rosen, A., M. Klein, A. Beck, J. Spona: Hyperandrogenemia as a cause of primary infertility. Gynecol. Obstet. Invest. 29 (1990) 145-148.
91. Rosenfield, R. L., R. B. Barnes, J. F. Cara, A. W. Lucky: Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome. Fertil. Steril. 53 (1990) 785-791.
92. Rosner, W., D. P. Aden, M. S. Kahn: Hormonal influences on the secretion of steroid-binding proteins by a human hepatomaderived cell line. J. Clin. Endocrinol. Metab. 59 (1984) 806-808.
93. Rosner, W.: Plasma steroid-binding proteins. Endocrinol. Metab. Clin. N. Amer. 20 (1991) 697-720.
94. Rouru, J., L. Anttila, P. Koskinen, T. A. Penttilä, K. Irjala, R. Huupponen, M. Koulu: Serum leptin concentrations in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 82 (1997) 1697-1700.
95. Sahin, Y., F. Kelestimur: 17-Hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome. Clin. Endocrinol. 39 (1993) 151-155.
96. Schoenfeld, H., V. Amir, P. Lichtenberg, B. Gaulayev: Secondary amenorrhoea: two kinds of psychogenic disorder - a case report. Int. J. Psychiatry Med. 20 (1990) 393-404.
97. Schurmeyer, T. H.: Dynamische Systemerkrankungen - Streß. In: Hesch, R. D. (Hrsg.): Endokrinologie, Teil B. Urban & Schwarzenberg Verlag. München (1989) 1221-1232.
98. Scott, M. G., J. H. Ladenson: Hormonal evaluation of female infertility and reproductive disorders (Washington University case conference). Clin. Chem. 35 (1989) 620-629.
99. Serafini, P., F. Ablan, R. A. Lobo: 5α-reductase activity in the genital skin of hirsute women. J. Clin. Endocrinol. Metab. 60 (1985) 349-355.
100. Serafini, P., R. A. Lobo: Increased 5α-reductase activity in idiopathic hirsutism. Fertil. Steril. 43 (1985) 74-78.
101. Seshadri, L., S. John. S. S. George, M. S. Seshadri: Endocrine profile of women with amenorrhea. Int. J. Gynecol. Obstet. 45 (1994) 247-252.
102. Simard, J., E Rheaume, F. Mebarki, R. Sanchez, M. I. New, Y. Morel, F. Labrie: Molecular basis of human 3 beta-hydroxysteroid dehydrogenase deficiency. J. Steroid. Biochem. Mol. Biol. 53 (1995) 127-138.
103. rd ed. Williams and Wilkins, Baltimore (1983).
104. Stewart, P. M., C. H. L. Shackleton, G. H. Beastall, C. R. W. Edwards: 5α-reductase activity in polycystic ovary syndrome. Lancet 335, 1 (1990) 431-433.
105. Suri, M., M. Kabra, U. Jain, V. Sanders, R. Saxena, A. Shukla, G. V. Singh, I. C. Verma: a clinical and cytogenetic study of Turner syndrome. Indian. Pediatr. 32 (1995) 433-442.
106. Tarkan, Y., S. Hacihanefioglu, A. N. Silahtaroglu, A. Deviren, D. Topcuoglu, A. Cenani: De novo X/X translocation in a patient with secondary amenorrhea. Hereditas 122 (1995) 19-23.
107. Therman, E., B. Susman: The similarity of phenotypic effects caused by Xp and Xq deletions in the human female: a hypothesis. Hum. Genet. 85 (1990) 175-183.
108. Thomas, R., R. L. Reid: Thyroid disease and reproductive dysfunktion: a review. Obstet. Gynecol. 70 (1987) 789-798.
109. ToJo, K., M. Ichinose, M. Nakayama, H. Yamamoto, T. Hasegawa, Y. Kawaguchi, S. C. Sealfon, O. Sakai: A new family of Boucher-Neuhauser syndrome: coexistence of Holmes type cerebellar atrophy, hypogonadotropic hypogonadism and retinochoroidal degeneration: case reports and review of literature. Endocr. J. 42 (1995) 367-376.
110. Uehara, S., Y. Obara, T. Obara, T. Funato, N. Yaegashi, T. Fukaya, A. Yajima: Trisomy 18 mosaicism associated with secondary amenorrhoea: ratios of mosaicism in different samples and complications. Clin. Genet. 49 (1996) 91-94.
111. Utiger, R. D.: Insulin and the polycystic ovary syndrome. N. Engl. J. Med. 335 (1996) 657-658.
112. Vermeulen, A., L. Verdonck, M. Van der Straeten, N. Orie: Capacity of the testosterone binding globulin in human plasma and influence of specific binding on testosterone and its metabolic clearance rate. J. Clin. Endocrinol. Metab. 29 (1969) 1470-1480.
113. Verschraegen-Spae, M. R., H. Depypere, F. Speleman, M. Dhont, A. De Paepe: Familial Turner syndrome. Clin. Genet. 41 (1992) 218-220.
114. Vutyavanich, T., S. Rugpao, C. Uttavichai, S. Tovanabutra, W. Ittipankul: Secondary amenorrhoea at Maharaj Nakhon Chiang Mai Hospital. J. Med. Assoc. Thai. 72 (1989) 160-166.
115. Waldstreicher, J., N. F. Santoro, J. E. Hall, M. Filcori, W. F. Crowley: Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J. Clin. Endocrinol. Metab. 66 (1988) 165-170.
116. Warren, M. P.: Evaluation of secondary amenorrhea. J. Clin. Endocrinol. Metab. 81 (1996) 437-442.
117. Weise, H. C., L. Moltz, C. Bispink, F. Leidenberger. Rationelle hormonale Diagnostik der Oligomenorrhö. Geburtsh. u. Frauenheilk. 49 (1989) 694-700.
118. Whelan, C. I., D. E. Stewart: Pseudocyesis - a review and report of six cases. Int. J. Psychiatry Med. 20 (1990) 97-108.
119. White, P. C., M. I. New, B. Dupont: Congenital adrenal hyperplasia. N. Engl. J. Med. 316 (1987) 1519-1524 und 1580-1586.
120. White, P. C., M. I. New: Genetic basis of endocrine disease 2: congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 74 (1992) 6-11.
121. Wieacker, P., D. Emmerich, M. Runge, M. Breckwoldt: Primäre Ovarialinsuffizienz beim Polyendokrinopathie-Syndrom. Geburtsh. u. Frauenheilk. 51 (1991) 1004-1005.
122. Wild, R. A.: Hyperandrogenism in the adolescent. Obstet. Gynecol. Clin. N. Amer. 19 (1992) 71-89.
123. Wildt, L., G. Leyendecker: Die endokrine Kontrolle des menstruellen Zyklus. Gynäkologe 14 (1981) 64-83.
124. Wu, R. C., P. L. Kuo, S. J. Lin, C. H. Liu, C. C. Tzeng: X-chromosome mosaicism in patients with recurrent abortion or premature ovarian failure. J. Formos. Med. Assoc. 92 (1993) 953-956.
125. Yen, S. S. C.: The polycystic ovary syndrome. Clin. Endocrinol. 12 (1980) 177-208.
126. Young, R. L., J. W. Goldzieher: Clinical manifestations in polycystic ovarian disease, EndocrinoL. Metab. Clin. N. Amer. 17 (1988) 621-635.
127. Zaadstra, B. M., J. C Seidell, P. A. H. Van Noord, E. R. te-VeLde, J. D. Habbema, B. Vrieswijk, J. Karbaat: Fat and female fecundity: prospective study of effect of body fat distribution on conception rates. Br. Med. J. 306 (1993) 484-487.
128. Zachmann, M.: Defects in steroidogenic enzymes. Discrepancies between clinical steroid research and molecular biology results. J. Steroid Biochem. Mol. Biol. 53 (1995) 159-164.
129. Zerah, M., P. Schram, M. I. New: The diagnosis and treatment of nonclassical 3β-HSD deficiency. The Endocrinologist 1 (1991) 75-81.